SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093943
Filing Date
2024-08-08
Accepted
2024-08-08 16:10:11
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q inab-20240630.htm   iXBRL 10-Q 1733962
2 EX-10.2 inab-ex10_2.htm EX-10.2 339736
3 EX-10.3 inab-ex10_3.htm EX-10.3 64154
4 EX-10.4 inab-ex10_4.htm EX-10.4 64493
5 EX-10.5 inab-ex10_5.htm EX-10.5 45578
6 EX-31.1 inab-ex31_1.htm EX-31.1 18222
7 EX-31.2 inab-ex31_2.htm EX-31.2 17702
8 EX-32.1 inab-ex32_1.htm EX-32.1 15172
9 GRAPHIC img239787466_0.jpg GRAPHIC 164719
  Complete submission text file 0000950170-24-093943.txt   7352526

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inab-20240630.xsd EX-101.SCH 980614
70 EXTRACTED XBRL INSTANCE DOCUMENT inab-20240630_htm.xml XML 891250
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39692 | Film No.: 241188363
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)